Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
AstraZeneca
UBS
Boehringer Ingelheim
Moodys
Daiichi Sankyo
US Army
Colorcon
Chinese Patent Office

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,333,992

« Back to Dashboard

Summary for Patent: 8,333,992
Title:Gastric retained gabapentin dosage form
Abstract: A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
Inventor(s): Berner; Bret (Half Moon Bay, CA), Hou; Sui Yuen Eddie (Foster City, CA), Gusler; Gloria M. (Cupertino, CA)
Assignee: Depomed, Inc. (Menlo Park, CA)
Application Number:13/560,938
Patent Claim Types:
see list of patent claims
Dosage form; Use;

Drugs Protected by US Patent 8,333,992

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Depomed Inc GRALISE gabapentin TABLET;ORAL 022544-001 Jan 28, 2011 BX RX Yes Yes ➤ Subscribe ➤ Subscribe Y TREATMENT WITH GABAPENTIN, INCLUDING TREATMENT OF NEUROPATHIC PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH POSTHERPETIC NEURALGIA ➤ Subscribe
Depomed Inc GRALISE gabapentin TABLET;ORAL 022544-002 Jan 28, 2011 BX RX Yes Yes ➤ Subscribe ➤ Subscribe Y TREATMENT WITH GABAPENTIN, INCLUDING TREATMENT OF NEUROPATHIC PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH POSTHERPETIC NEURALGIA ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,333,992

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,192,756 Gastric retained gabapentin dosage form ➤ Subscribe
8,475,813 Methods of treatment using a gastric retained gabapentin dosage ➤ Subscribe
7,438,927 Methods of treatment using a gastric retained gabapentin dosage ➤ Subscribe
8,333,991 Gastric retained gabapentin dosage form ➤ Subscribe
8,802,157 Methods of treatment using a gastric retained gabapentin dosage form ➤ Subscribe
8,592,481 Gastric retentive gabapentin dosage forms and methods for using same ➤ Subscribe
8,529,955 Methods of treatment using a gastric retained gabapentin dosage ➤ Subscribe
8,580,303 Gastric retained gabapentin dosage form ➤ Subscribe
7,612,112 Methods of treatment using a gastric retained gabapentin dosage ➤ Subscribe
8,231,905 Gastric retained gabapentin dosage form ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,333,992

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Taiwan 200800155 ➤ Subscribe
Taiwan I312285 ➤ Subscribe
Mexico 2007001187 ➤ Subscribe
Mexico PA04003946 ➤ Subscribe
Japan 2010254713 ➤ Subscribe
Japan 2009522294 ➤ Subscribe
Japan 2008508317 ➤ Subscribe
Japan 5421511 ➤ Subscribe
Japan 2005507400 ➤ Subscribe
European Patent Office 2266539 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Farmers Insurance
Baxter
Deloitte
Express Scripts
Fuji
AstraZeneca
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot